Relationship between CTF1 gene expression and prognosis and tumor immune microenvironment in glioma

被引:0
作者
Cai, Hongqing [1 ,2 ]
Tian, Shen [1 ,2 ]
Liu, Angsi [1 ,2 ]
Xie, Guanchao [1 ,2 ,3 ]
Zhang, Hongsheng [1 ,2 ,3 ]
Wu, Xiaogang [4 ]
Wan, Jinghai [1 ,2 ,3 ]
Li, Sai [1 ,2 ,3 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Neurosurg, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, State Key Lab Mol Oncol, Beijing, Peoples R China
[3] Anhui Med Univ, Affiliated Hosp 2, Dept Neurosurg, 678 Furong Rd, Econ & Technol Dev Zone, Hefei 230000, Anhui, Peoples R China
[4] 901 Hosp Chinese Peoples Liberat Army Logist Suppo, Dept Neurosurg, 424 Changjiang West Rd, Hefei 230000, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
CTF1; Glioma; Prognosis; Immune microenvironment; Proliferation; GLIOBLASTOMA; CANCER; IDH;
D O I
10.1186/s40001-024-02192-w
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
ObjectiveThis study aimed to evaluate CTF1 expression in glioma, its relationship to patient prognosis and the tumor immune microenvironment, and effects on glioma phenotypes to identify a new therapeutic target for treating glioma precisely.MethodsWe initially assessed the expression of CTF1, a member of the IL-6 family, in glioma, using bioinformatics tools and publicly available databases. Furthermore, we examined the correlation between CTF1 expression and tumor prognosis, DNA methylation patterns, m6A-related genes, potential biological functions, the immune microenvironment, and genes associated with immune checkpoints. We also explored potential associations with drug sensitivity. To assess the impact on glioma cell proliferation and apoptosis, we employed various assays, including the Cell Counting Kit-8, colony formation assay, and flow cytometry.ResultsCTF1 gene and protein expression were significantly elevated in glioma tissues, and correlated with malignancy and poor prognosis. CTF1 was an independent prognostic factor and negatively associated with DNA methylation. The involvement of CTF1 in m6A modifications contributed to glioma progression. Enrichment analysis revealed immune response pathways linked with CTF1 in glioma, including natural killer cell cytotoxicity, NOD-like receptor signaling, Toll-like receptor signaling, antigen processing, chemokine signaling, and cytokine receptor interactions. CTF1 expression correlated positively with pathways related to apoptosis, inflammation, proliferation, and epithelial-mesenchymal transition, and PI3K-AKT-mTOR signaling. Additionally, CTF1 expression was positively associated with macrophage, eosinophil, and neutrophil contents and immune checkpoint-related genes, but negatively associated with sensitivity to 14 drugs. In vitro experiments confirmed that CTF1 knockdown inhibited glioma cell proliferation and promoted apoptosis.ConclusionThis study identifies CTF1 as a significant independent prognostic factor that is closely associated with the tumor immune microenvironment in glioma. Additionally, reduced expression of CTF1 suppresses the proliferation and induces apoptosis of glioma cells in vitro. Consequently, CTF1 is a potentially promising novel therapeutic target for glioma treatment.
引用
收藏
页数:15
相关论文
共 50 条
[1]   N-acetyl cysteine can blunt metabolic and cardiovascular effects via down-regulation of cardiotrophin-1 in rat model of fructose-induced metabolic syndrome [J].
Abdelhaffez, Azza S. ;
Abd El-Aziz, Ebtihal A. ;
Tohamy, Maha B. ;
Ahmed, Asmaa M. .
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2023, 129 (04) :854-869
[2]   Cardiotrophin 1 stimulates beneficial myogenic and vascular remodeling of the heart [J].
Abdul-Ghani, Mohammad ;
Suen, Colin ;
Jiang, Baohua ;
Deng, Yupu ;
Weldrick, Jonathan J. ;
Putinski, Charis ;
Brunette, Steve ;
Fernando, Pasan ;
Lee, Tom T. ;
Flynn, Peter ;
Leenen, Frans H. H. ;
Burgon, Patrick G. ;
Stewart, Duncan J. ;
Megeney, Lynn A. .
CELL RESEARCH, 2017, 27 (10) :1195-1215
[3]   SnapShot: Immune Checkpoint Inhibitors [J].
Abril-Rodriguez, Gabriel ;
Ribas, Antoni .
CANCER CELL, 2017, 31 (06)
[4]   Tumor-derived CTF1 (cardiotrophin 1) is a critical mediator of stroma-assisted and autophagy-dependent breast cancer cell migration, invasion and metastasis [J].
Akkoc, Yunus ;
Dalci, Kubilay ;
Karakas, Hacer Ezgi ;
Erbil-Bilir, Secil ;
Yalav, Orcun ;
Sakman, Gurhan ;
Celik, Faruk ;
Arikan, Soykan ;
Zeybek, Umit ;
Ergin, Melek ;
Akkiz, Hikmet ;
Dilege, Ece ;
Dengjel, Joern ;
Dogan-Ekici, A. Isin ;
Gozuacik, Devrim .
AUTOPHAGY, 2023, 19 (01) :306-323
[5]  
Armstrong TS, 2020, LANCET ONCOL, V21, pE97, DOI 10.1016/S1470-2045(19)30796-X
[6]   World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas A Review [J].
Berger, Tamar R. ;
Wen, Patrick Y. ;
Lang-Orsini, Melanie ;
Chukwueke, Ugonma N. .
JAMA ONCOLOGY, 2022, 8 (10) :1493-1501
[7]   Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer [J].
Chen, Pin ;
Xu, Jing ;
Cui, Zihan ;
Wu, Silin ;
Xie, Tao ;
Zhang, Xiaobiao .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[8]   Glioblastoma Immune Landscape and the Potential of New Immunotherapies [J].
Daubon, Thomas ;
Hemadou, Audrey ;
Romero Garmendia, Irati ;
Saleh, Maya .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[9]   The evolving tumor microenvironment From cancer initiation to metastatic outgrowth [J].
de Visser, Karin E. ;
Joyce, Johanna A. .
CANCER CELL, 2023, 41 (03) :374-403
[10]   The roles and implications of RNA m6A modification in cancer [J].
Deng, Xiaolan ;
Qing, Ying ;
Horne, David ;
Huang, Huilin ;
Chen, Jianjun .
NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (08) :507-526